Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 107

Results For "PORTFOLIO"

1680 News Found

Medico Remedies to foray into ointment manufacturing segment
News | May 15, 2023

Medico Remedies to foray into ointment manufacturing segment

The facility will have a capacity to manufacture upto 3 million tubes monthly


Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr
News | May 13, 2023

Cipla reports Q4 FY 23 consolidated PAT at Rs. 525.65 Cr

Cipla has reported total income of Rs. 5873.93 crores during the period ended March 31, 2023


Sanofi India to demerge healthcare businesses
News | May 12, 2023

Sanofi India to demerge healthcare businesses

This decision will accelerate growth for both its pharma & consumer healthcare businesses in India


USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Drug Approval | May 12, 2023

USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’

Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time


Gilead acquires XinThera to strengthen pipeline in oncology
News | May 12, 2023

Gilead acquires XinThera to strengthen pipeline in oncology

Acquisition of XinThera provides Gilead with precision small molecules focused on PARP1 and MK2 Inhibitors


Evonik partners with Safic-Alcan to boost offering of advanced food ingredients
News | May 11, 2023

Evonik partners with Safic-Alcan to boost offering of advanced food ingredients

Wider reach for nutraceuticals portfolio in Europe, Turkey and Egypt


FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS
News | May 11, 2023

FSD Pharma completes dosing of first cohort in Phase I clinical trial of Lucid-MS

Lucid-MS is a new drug candidate for the treatment of multiple sclerosis


IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market
Drug Approval | May 09, 2023

IOL Chemicals and Pharmaceuticals receives CEP for Paracetamol to export in European market

The certification issued by the EDQM verifies the compliance of pharmaceutical substances


Galmed Pharmaceuticals forms partnership with OnKai
News | May 08, 2023

Galmed Pharmaceuticals forms partnership with OnKai

Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications


Wacker acquires Spain-based biotech firm ADL BioPharma
News | May 08, 2023

Wacker acquires Spain-based biotech firm ADL BioPharma

The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters